Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma
Clinical trial NCT00644696 · COMPLETED
Trial details
- NCT number
- NCT00644696
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2012-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.